NOVA1 anticorps (AA 315-507)
Aperçu rapide pour NOVA1 anticorps (AA 315-507) (ABIN1886360)
Antigène
Voir toutes NOVA1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 315-507
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 315 and 507 of NOVA1
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Autre désignation
- NOVA1
-
Sujet
-
This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies.These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer.Alternatively spliced transcripts encoding distinct isoforms have been described.[provided by RefSeq]
-
Poids moléculaire
- 52 kDa
-
ID gène
- 4857
-
NCBI Accession
- NP_002506, NM_002515
Antigène
-